Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

NCT00112658 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

342

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: fluorouracil
DRUG: gemcitabine hydrochloride
DRUG: irinotecan hydrochloride
DRUG: leucovorin calcium
DRUG: oxaliplatin

Sponsor

UNICANCER